SMTL ID : 5xzr.1

The atomic structure of SHP2 E76A mutant in complex with allosteric inhibitor 9b

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x 8J6: 4-(3-phenylphenyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-thiazol-2-amine(Non-covalent)

8J6.1: 14 residues within 4Å: Chain A: T.131, E.133, R.134, F.136, H.137, N.240, T.241, T.242, E.272, E.273, T.276, L.277, P.514, K.515 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:T.276, A:L.277, A:P.514, A:K.515, A:K.515 Hydrogen bonds: A:R.134, A:F.136 pi-Cation interactions: A:R.134

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Xie, J. et al., Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment. J. Med. Chem. (2017)

Release Date

2017-12-13

Peptides

Tyrosine-protein phosphatase non-receptor type 11: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein phosphatase non-receptor type 11